Ziprasidone for the Treatment of Generalized Anxiety in Patients With Bipolar Disorder

Summary

This study proposes to examine the potential safety and efficacy of ziprasidone for patients with anxiety and bipolar disorder on anxiety outcomes, bipolar symptoms, and on measures of quality of life and resilience.

Timeline

Start

2006-02

Primary completion

2007-10

Completion

2008-11

Outcome

Outcome not reported

Stopped (Enrollment): “Recruitment goal could not be achieved”

Drugs

Indications